Bandelow, Borwin

[["dc.bibliographiccitation.firstpage","42"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE"],["dc.bibliographiccitation.lastpage","57"],["dc.bibliographiccitation.volume","47"],["dc.contributor.author","Doering, Stefan"],["dc.contributor.author","Wedekind, Dirk"],["dc.contributor.author","Pilz, J."],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Adler, L."],["dc.contributor.author","Huether, Gerald"],["dc.date.accessioned","2018-11-07T09:41:12Z"],["dc.date.available","2018-11-07T09:41:12Z"],["dc.date.issued","2001"],["dc.description.abstract","Cortisol is one of the major parameters investigated in psychoneuroendocrinological research, but the methods employed for sample collecting are often unsatisfactory, A suitable method of sample collection should allow for the integrative assessment of long-term changes of the HPA-system, should be non-invasive, and should not exceed the subject's compliance. The assessment of cortisol in night-urine fulfils these demands; although this method has been occasionally employed, it has not yet been described systematically, For the first time a detailed description is given here that allows for a standardized replication. In ten previous studies and three investigations of our own this method has been successfully applied to detect changes in the cortisol excretion of patients with endocrinological and psychiatric disorders as well as in subjects under conditions of psychosocial stress. The determination of cortisol in night-urine represents an ideal method for the assessment of changes in the basal HPA-activity in numerous areas of psychoneuroendocrinological research, e.g. field and screening studies in natural environment, clinical studies in psychiatry and especially follow-up studies in psychotherapy research."],["dc.identifier.isi","000166985000003"],["dc.identifier.pmid","11593453"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/33678"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Vandenhoeck & Ruprecht"],["dc.relation.issn","1438-3608"],["dc.title","Cortisol in night-urine: Introduction of a research method in psychoneuroendocrinology"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","616"],["dc.bibliographiccitation.issue","10"],["dc.bibliographiccitation.journal","Fortschritte der Neurologie · Psychiatrie"],["dc.bibliographiccitation.lastpage","620"],["dc.bibliographiccitation.volume","76"],["dc.contributor.author","Wedekind, Dirk"],["dc.contributor.author","Engel, Katharina"],["dc.contributor.author","Bandelow, Borwin"],["dc.date.accessioned","2018-11-07T11:10:31Z"],["dc.date.available","2018-11-07T11:10:31Z"],["dc.date.issued","2008"],["dc.identifier.doi","10.1055/s-2008-1038201"],["dc.identifier.isi","000260387300013"],["dc.identifier.pmid","18833508"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/53227"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Georg Thieme Verlag Kg"],["dc.relation.issn","0720-4299"],["dc.title","Social Anxiety Disorder - Diagnostics and Treatment Options"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","635"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Der Nervenarzt"],["dc.bibliographiccitation.lastpage","644"],["dc.bibliographiccitation.volume","85"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Wedekind, Dirk"],["dc.date.accessioned","2018-11-07T09:40:47Z"],["dc.date.available","2018-11-07T09:40:47Z"],["dc.date.issued","2014"],["dc.description.abstract","With a lifetime prevalence of 13 % social phobia (social anxiety disorder) is a common and serious condition that should not be played down because of the burden associated with the disorder, an increased suicide rate and the frequent comorbidity with substance abuse disorders. Social phobia is characterized by the excessive and unrealistic fear of being scrutinized or criticized by others. The disorder often begins in adolescence. Symptoms of social phobia can be effectively treated with evidence-based treatment, including cognitive behavior therapy (CBT) and psychopharmacological medications. In the present paper, treatment recommendations are given, which are based on a systematic review of all available randomized trials for the treatment of social phobia. Among psychological therapies, variants of CBT have been proven to be effective in controlled studies. Selective serotonin reuptake inhibitors (SSRIs) and the selective serotonin norepinephrine reuptake inhibitor (SNRI) venlafaxine are among the drugs of first choice."],["dc.identifier.doi","10.1007/s00115-013-3955-9"],["dc.identifier.isi","000335660700017"],["dc.identifier.pmid","24718882"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/33576"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.relation.issn","1433-0407"],["dc.relation.issn","0028-2804"],["dc.title","Social phobia"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","831"],["dc.bibliographiccitation.issue","7"],["dc.bibliographiccitation.journal","Journal of Neural Transmission"],["dc.bibliographiccitation.lastpage","837"],["dc.bibliographiccitation.volume","107"],["dc.contributor.author","Wedekind, Dirk"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Broocks, Andreas"],["dc.contributor.author","Hajak, Goran"],["dc.contributor.author","Ruther, Eckart"],["dc.date.accessioned","2018-11-07T11:09:47Z"],["dc.date.available","2018-11-07T11:09:47Z"],["dc.date.issued","2000"],["dc.description.abstract","Background. Research on basal HPA axis activity in patients with panic disorder showed inconsistent results. Methods. Basal total plasma, plasma free and salivary cortisol levels were compared in patients with panic disorder (n = 47) and in healthy individuals (n = 23). Correlations between these fractions were calculated. Results. All three basal cortisol fractions were significantly elevated in patients compared to controls. There were significant correlations between all three cortisol fractions. Conclusions. Nonsignificant differences between cortisol levels of patients and healthy controls in previous studies may have been due to inclusion of less severely ill patients or to small sample sizes (96 words)."],["dc.identifier.doi","10.1007/s007020070062"],["dc.identifier.isi","000088415100008"],["dc.identifier.pmid","11005547"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/53083"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","Wien"],["dc.relation.issn","0300-9564"],["dc.title","Salivary, total plasma and plasma free cortisol in panic disorder"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","333"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","The British Journal of Psychiatry"],["dc.bibliographiccitation.lastpage","338"],["dc.bibliographiccitation.volume","212"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Sagebiel, Anne"],["dc.contributor.author","Belz, Michael"],["dc.contributor.author","Görlich, Yvonne"],["dc.contributor.author","Michaelis, Sophie"],["dc.contributor.author","Wedekind, Dirk"],["dc.date.accessioned","2020-12-10T18:41:28Z"],["dc.date.available","2020-12-10T18:41:28Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1192/bjp.2018.49"],["dc.identifier.eissn","1472-1465"],["dc.identifier.issn","0007-1250"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77588"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","441"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","BMC Psychiatry"],["dc.bibliographiccitation.volume","22"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Wedekind, Dirk"],["dc.date.accessioned","2022-07-01T07:35:22Z"],["dc.date.available","2022-07-01T07:35:22Z"],["dc.date.issued","2022"],["dc.date.updated","2022-07-25T11:18:54Z"],["dc.description.abstract","Background During the COVID-19 pandemic, internet-delivered psychotherapeutic interventions (IPI) move increasingly into the focus of attention. Method We reviewed 39 randomized controlled studies of IPIs with 97 study arms ( n  = 4122 patients) for anxiety disorders (panic disorder/agoraphobia, generalized anxiety disorder, and social anxiety disorder) and performed a meta-analysis. Most studies were conducted with cognitive behavioural approaches (iCBT). Results were compared with a previous meta-analysis examining medications and face-to-face (F2F) psychotherapy. Results In direct comparisons, IPIs were as effective as F2F-CBT and superior to waitlist controls. Programs with more intensive therapist contact yielded higher effect sizes (ES). We compared the obtained ES with a previous comprehensive meta-analysis of 234 studies. In this comparison, iCBT was less effective than individual F2F-CBT and medications, not different from pill placebos, and more effective than psychological placebo and waitlist ( p  > .0001 for all comparisons). ES of IPIs may be overestimated. Treatments were only compared to waitlist, which is not a sufficient control condition. 97% of the studies were not blinded with regard to the main outcome measure. 32% of the participants received antianxiety drugs during the trials. In 89%, participants were recruited by advertisements rather than from clinical settings, and 63% of the participants had an academic background (students or university employees) which might affect the generalizability of the findings. Remote diagnoses were often made by students without completed training in psychotherapy. In only 15% of the studies, diagnoses were made in personal contact with a psychiatrist or psychologist. In 44% of the studies, the ‘therapists’ maintaining remote contact with the participants were mostly students without completed psychotherapy education. Conclusions IPIs may be a useful tool when face-to-face psychotherapy is not easily available, or as an add-on to standard psychotherapeutic or psychopharmacological treatments but should perhaps not be used as monotherapy. We have suggested standards for future research and the practical use of IPIs."],["dc.description.sponsorship","Open-Access-Publikationsfonds 2022"],["dc.identifier.citation","BMC Psychiatry. 2022 Jun 29;22(1):441"],["dc.identifier.doi","10.1186/s12888-022-04002-1"],["dc.identifier.pii","4002"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/112151"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-581"],["dc.relation.eissn","1471-244X"],["dc.rights","CC BY 4.0"],["dc.rights.holder","The Author(s)"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.subject","Anxiety disorders"],["dc.subject","Panic disorder"],["dc.subject","Generalised anxiety disorder"],["dc.subject","Social anxiety disorder"],["dc.subject","Internet psychotherapy"],["dc.subject","Meta-analysis"],["dc.title","Internet psychotherapeutic interventions for anxiety disorders – a critical evaluation"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","393"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","Human Psychopharmacology Clinical and Experimental"],["dc.bibliographiccitation.lastpage","415"],["dc.bibliographiccitation.volume","30"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Wedekind, Dirk"],["dc.date.accessioned","2018-11-07T09:49:33Z"],["dc.date.available","2018-11-07T09:49:33Z"],["dc.date.issued","2015"],["dc.description.abstract","Around half the inmates in prison institutions have antisocial personality disorder (ASPD). A recent theory has proposed that a dysfunction of the endogenous opioid system (EOS) underlies the neurobiology of borderline personality disorder (BPD). In the present theoretical paper, based on a comprehensive database and hand search of the relevant literature, this hypothesis is extended to ASPD, which may be the predominant expression of EOS dysfunction in men, while the same pathology underlies BPD in women. According to evidence from human and animal studies, the problematic behaviours of persons with antisocial, callous, or psychopathic traits may be seen as desperate, unconscious attempts to stimulate their deficient EOS, which plays a key role in brain reward circuits. If the needs of this system are not being met, the affected persons experience dysphoric mood, discomfort, or irritability, and strive to increase binding of endogenous opioids to receptors by using the rewarding effects of aggression by exertion of physical or manipulative power on others, by abusing alcohol or substances that have the reward system as target, by creating an endorphin rush by self-harm, by increasing the frequency of their sexual contacts, or by impulsive actions and sensation seeking. Symptoms associated with ASPD can be treated with opioid antagonists like naltrexone, naloxone, or nalmefene. Copyright (c) 2015 John Wiley & Sons, Ltd."],["dc.identifier.doi","10.1002/hup.2497"],["dc.identifier.isi","000364641400001"],["dc.identifier.pmid","26250442"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/35531"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.relation.issn","1099-1077"],["dc.relation.issn","0885-6222"],["dc.title","Possible role of a dysregulation of the endogenous opioid system in antisocial personality disorder"],["dc.type","review"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1163"],["dc.bibliographiccitation.issue","16"],["dc.bibliographiccitation.journal","Journal of Psychiatric Research"],["dc.bibliographiccitation.lastpage","1169"],["dc.bibliographiccitation.volume","44"],["dc.contributor.author","Wedekind, Dirk"],["dc.contributor.author","Herchenhein, Thomas"],["dc.contributor.author","Kirchhainer, Julia"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Falkai, Peter"],["dc.contributor.author","Engel, Kirsten"],["dc.contributor.author","Malchow, Berend"],["dc.contributor.author","Havemann-Reinecke, Ursula"],["dc.date.accessioned","2018-11-07T08:36:24Z"],["dc.date.available","2018-11-07T08:36:24Z"],["dc.date.issued","2010"],["dc.description.abstract","Alcohol addiction is associated with alterations of central nervous dopaminergic and serotonergic functions. Acute tryptophan depletion has not yet been applied in detoxified alcohol-addicted patients in order to investigate its impact on psychopathology, psychoneuroendocrinology, and substance craving behaviour. 25 alcohol-addicted males randomly either received a tryptophan-free or tryptophan-containing amino acid drink and 7 days later the respective other drink. Anxiety, depression, and craving were assessed before and 5 h after the drink. Tryptophan, 5-HIAA, dopamine, norepinephrine, epinephrine, and HVA in serum were measured before and after both treatments. Nocturnal urinary cortisol measurements and genotyping for the HTTLPR polymorphism of the SLC6A4 gene were performed. Tryptophan depletion resulted in a significant reduction of total and free serum tryptophan while the tryptophan-rich drink increased serum levels. Both treatments caused a significant increase of serum serotonin levels, however, serum 5-HIAA was decreased after depletion but increased after sham depletion. Dopamine and norepinephrine were elevated after tryptophan depletion and sham. Depletion increased depression scores (MADRS), while the full amino acid drink improved state and trait anxiety ratings (STAI) and substance craving. Urinary cortisol excretion was not affected by both treatments. Patients with the II genotype of the serotonin transporter gene displayed lower baseline tryptophan levels compared to patients with the heterozygous genotype. Results suggest an impaired serotonergic function in alcohol-addicted males. (C) 2010 Elsevier Ltd. All rights reserved."],["dc.identifier.doi","10.1016/j.jpsychires.2010.04.002"],["dc.identifier.isi","000285952000007"],["dc.identifier.pmid","20579662"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/18303"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Pergamon-elsevier Science Ltd"],["dc.relation.issn","0022-3956"],["dc.title","Serotonergic function, substance craving, and psychopathology in detoxified alcohol-addicted males undergoing tryptophan depletion"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","769"],["dc.bibliographiccitation.issue","7"],["dc.bibliographiccitation.journal","Expert Review of Neurotherapeutics"],["dc.bibliographiccitation.lastpage","781"],["dc.bibliographiccitation.volume","7"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Wedekind, Dirk"],["dc.contributor.author","Leon, Teresa"],["dc.date.accessioned","2021-06-01T10:48:26Z"],["dc.date.available","2021-06-01T10:48:26Z"],["dc.date.issued","2014"],["dc.identifier.doi","10.1586/14737175.7.7.769"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/85938"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-425"],["dc.relation.eissn","1744-8360"],["dc.relation.issn","1473-7175"],["dc.title","Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","369"],["dc.bibliographiccitation.issue","06"],["dc.bibliographiccitation.journal","Aktuelle Neurologie"],["dc.bibliographiccitation.lastpage","371"],["dc.bibliographiccitation.volume","43"],["dc.contributor.author","Zerr, Inga"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Wedekind, D."],["dc.contributor.author","Schneider, A."],["dc.contributor.author","Radenbach, K."],["dc.contributor.author","Wiltfang, Jens"],["dc.contributor.author","Bähr, Mathias"],["dc.date.accessioned","2017-09-07T11:44:36Z"],["dc.date.available","2017-09-07T11:44:36Z"],["dc.date.issued","2016"],["dc.description.abstract","Patienten mit neurologischen bzw. psychiatrischen Erkrankungen bedürfen häufig einer Behandlungsexpertise durch beide Fachrichtungen. Zahlreiche Beispiele sind bekannt, bei denen eine fachübergreifende Therapieeinleitung und Bahnung einer Weiterbehandlung notwendig sind. Dazu gehören z. B. neurodegenerative Erkrankungen, ZNS-Erkrankung mit komorbider psychiatrischer Symptomatik (z. B. Schlaganfall, enzephalitis disseminata, M. Parkinson), nur um einige zu nennen. Eine enge Verknüpfung der beiden beteiligten Disziplinen führt zur Verbesserung der diagnostischen und therapeutischen Entscheidungen. Im nachfolgenden Beitrag präsentieren wir das an der Universitätsmedizin Göttingen realisierte interdisziplinäre Konzept."],["dc.identifier.doi","10.1055/s-0042-106719"],["dc.identifier.fs","625007"],["dc.identifier.gro","3151696"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/8515"],["dc.language.iso","de"],["dc.notes.status","final"],["dc.notes.submitter","chake"],["dc.relation.issn","0302-4350"],["dc.subject","Demenz; Neurologie; Psychiatrie; Demenzzentrum; Interdisziplinarität"],["dc.title","Neuropsychiatrische Erkrankungen und Demenzen: ein interdisziplinärer Ansatz"],["dc.title.alternative","Neuropsychiatric Disorders and Dementia: An Interdisciplinary Concept"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dc.type.peerReviewed","no"],["dspace.entity.type","Publication"]]